Technical Analysis for BSGM - BioSig Technologies, Inc.

Grade Last Price % Change Price Change
F 0.55 3.43% 0.02
BSGM closed up 3.43 percent on Monday, March 18, 2024, on 22 percent of normal volume.
2 Watchers
Watchlist Portfolio

Trend Table & Recent EOD Trading Signals

ADX Long Term Intermediate Term Short Term
Weak or Absent Down Down Down

Date Alert Name Type % Chg
20 DMA Resistance Bearish 0.00%
Narrow Range Bar Range Contraction 0.00%
Inside Day Range Contraction 0.00%
Wide Bands Range Expansion 0.00%
Gapped Up Strength 0.00%
20 DMA Resistance Bearish 3.43%
Shooting Star Candlestick Bearish 3.43%
New Uptrend Bullish 3.43%
Doji - Bearish? Reversal 3.43%
Wide Bands Range Expansion 3.43%

   Recent Intraday Alerts

Alert Time
Possible Inside Day about 15 hours ago
Down 3% about 15 hours ago
Down 2 % about 15 hours ago
60 Minute Opening Range Breakdown about 16 hours ago
Down 1% about 16 hours ago

Get this analysis on your stocks daily!

Let us help you stay on top of your investments. We will alert you to important technical developments on your portfolio & watchlist.

Profile

BioSig Technologies, Inc. Description

BioSig Technologies is a medical device company developing a proprietary biomedical signal processing technology designed to improve the $4.6 billion electrophysiology (EP) marketplace (www.biosigtech.com). Led by a proven management team and a veteran, independent Board of Directors, Los Angeles-based BioSig Technologies is preparing to commercialize its PURE EP(TM) System. The technology has been developed to address an unmet need in a large and growing market. The Company’s first product, PURE EP(TM) System, is a novel cardiac signal acquisition and display system which is engineered to assist electrophysiologists in clinical decision making during procedures to diagnose and treat patients with abnormal heart rates and rhythms. BioSig’s main goal is to deliver technology to improve upon catheter ablation treatments for the prevalent and potentially deadly arrhythmias: Atrial Fibrillation and Ventricular Tachycardia. BioSig has partnered with Minnetronix on technology development and received FDA 510(k) clearance for the PURE EP(TM) System in August 2018.


Classification

Sector: Healthcare
Industry: Medical Devices
Keywords: Catheter FDA Ablation Technology Development Cardiac Electrophysiology Cardiac Arrhythmia Signal Processing Physiology Atrial Fibrillation Electrophysiology Cardiovascular System Circulatory System Arrhythmia Processing Technology Catheter Ablation Tachycardia Ventricular Tachycardia

Is BSGM a Buy, Sell or Hold?

Indicator Bull Case Neutral / Hold Bear Case
50 DMA
200 DMA
ADX Trend
Oversold / Overbought
Relative Strength

Indicators

Indicator Value
52 Week High 16.5
52 Week Low 0.2619
Average Volume 405,115
200-Day Moving Average 5.38
50-Day Moving Average 1.42
20-Day Moving Average 0.55
10-Day Moving Average 0.57
Average True Range 0.15
RSI (14) 37.50
ADX 24.68
+DI 25.61
-DI 23.76
Chandelier Exit (Long, 3 ATRs) 0.42
Chandelier Exit (Short, 3 ATRs) 0.70
Upper Bollinger Bands 0.79
Lower Bollinger Band 0.32
Percent B (%b) 0.49
BandWidth 84.92
MACD Line -0.22
MACD Signal Line -0.29
MACD Histogram 0.0672
Fundamentals Value
Market Cap 5.12 Million
Num Shares 9.33 Million
EPS -4.70
Price-to-Earnings (P/E) Ratio -0.12
Price-to-Sales 61.24
Price-to-Book 36.58
PEG Ratio 0.00
Pivot Point Level Traditional / Classic Fibonacci Demark Woodie Camarilla
Resistance 4 (R4) 0.65
Resistance 3 (R3) 0.65 0.61 0.63
Resistance 2 (R2) 0.61 0.59 0.61 0.63
Resistance 1 (R1) 0.58 0.57 0.56 0.58 0.62
Pivot Point 0.55 0.55 0.54 0.55 0.55
Support 1 (S1) 0.51 0.52 0.50 0.51 0.48
Support 2 (S2) 0.48 0.50 0.48 0.47
Support 3 (S3) 0.45 0.48 0.46
Support 4 (S4) 0.45